详细信息
- ;N-[(2R,3S)-2-(2,5-二氟苯基)四氢-5-氧-2H-吡喃-3-基]-氨基甲酸 1,1-二甲基乙基酯;MK-3102 中间体1;N-[(2R,3S)-2-(2,5-二氟苯基)四氢-5-氧代-2H-吡喃-3-基]氨基甲酸叔丁酯;(OMARIGLIPTIN)MK3102中间体;奥格列汀中间体1;N-[(2R,3S)-2-(2,5-二氟苯基)-5-羟基-四氢-2H-吡喃-3-基]氨基甲酸叔丁酯;奥格列汀中间体;(2,5-二氟苯基)四氢-5-氧代-2H-吡喃-3-基]氨基甲酸叔丁酯;
- CPo3604-01
- ;tert-butyl [(2R,3S)-5-oxo-2-(2,5-difluorophenyl)tetradihydro-2H-pyran-3-yl]carbamate;tert-butyl [(2R,3S)-2-(2,5-difluorophenyl)-5-oxotetrahydro-2H-pvran-3 yl]carbaMate;tert-butyl ((2R,3S)-2-(2,5-difluorophenyl)-5-oxotetrahydro-2H-pyran-3-yl)carbamate;N-[(2R,3S)-2-(2,5-difluorophenyl)tetrahydro-5-oxo-2H-pyran-3-yl]-Carbamic acid 1,1-dimethylethyl ester;MK-3102 intermediate 1;tert-butyl [(2R,3S)-5-oxo-2-(2,5-difluorophenyl) tetradihydro-2H-pyran-3-yl]carbamate;MK3102 intermediate;
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,化工网对此不承担任何保证责任。我们原则上建议您选择化工网高级会员或VIP会员。